National Institute for Health and Care Research

• Barts Health NHS Trust

  Programme Grants for Applied Research, Personalised prevention of breast cancer in people at moderate or high risk– a new approach to optimising prevention in primary care., NIHR208880, £3.3m, 2026–2031, 1 Oct 2026

• University Hospitals Plymouth NHS Trust

  Efficacy and Mechanism Evaluation, A randomised placebo-controlled superiority trial of GLP-1 receptor agonist for the treatment of alcohol use disorder in people with chronic liver disease and obesity: Controlling Unhealthy Relationships with Both alcohol and obesity (CURB trial), NIHR170284, £2.8m, 2026–2030, 1 Sept 2026

• Newcastle upon Tyne Hospitals NHS Foundation Trust

  Research for Patient Benefit, Feasibility and acceptability of a remote community exercise and lifestyle change intervention in patients with smaller abdominal aortic aneurysms, NIHR209270, £304.8k, 2026–2029, 1 Apr 2026

• NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board

  Health and Social Care Delivery Research, A mixed methods realist evaluation and economic appraisal of how health screening, education and prevention interventions in mosques impact the health and wellbeing of Muslim communities., NIHR174159, £770.2k, 2026–2029, 1 Apr 2026

• North London Nhs Foundation Trust

  Programme Grants for Applied Research, Treating auditory impairment to preserve cognition in people with mild cognitive impairment, NIHR501279, £3.5m, 2026–2031, 1 Apr 2026

• Midlands Partnership NHS Foundation Trust

  Programme Grants for Applied Research, PRevention of Osteoporotic fractures Through Equitable Case finding and Treatment Support (PROTECTS), NIHR209321, £4.9m, 2026–2032, 1 Apr 2026

• University College London

  Invention for Innovation, Quantum enabled neuromodulation for memory enhancement, NIHR517770, £100k, 2026–2027, 1 Mar 2026

• University College London

  Invention for Innovation, Quantum sensing to detect neurophysiological signatures of early Alzheimer’s disease, NIHR517481, £99k, 2026–2027, 1 Mar 2026

• University College London

  Efficacy and Mechanism Evaluation, REgression in Left ventrIcular hypErtrophy and Fibrosis in Aortic Stenosis – a randomised controlled trial (RELIEF-AS), NIHR170907, £2.8m, 2026–2030, 1 Mar 2026

• North Bristol NHS Trust

  Health Technology Assessment, Multimodal prehabilitation for frail patients undergoing total hip and knee replacement: The Joint PREP randomised controlled trial, NIHR171964, £2.4m, 2026–2029, 1 Mar 2026

• Imperial College London

  Public Health Research, Identifying and evaluating policy mechanisms to reduce ultra-processed food consumption in the UK: health, equity and economic impacts (The UPForesight Project), NIHR174105, £1.5m, 2026–2029, 1 Mar 2026

• University Hospitals of Derby and Burton NHS FoundationTrust

  Research for Patient Benefit, Effect of immuno-nutrition on markers of sarcopenia and systemic inflammation in a haemodialysis population: a feasibility randomised controlled trial., NIHR209189, £300.2k, 2026–2028, 2 Feb 2026

• Prodromic

  Invention for Innovation, Developing and validating ‘Sia’: a responsible AI platform for dementia prediction, NIHR505305, £1.5m, 2026–2029, 1 Feb 2026

• University of Exeter

  Public Health Research, SHIFTS-UPF: Study on Health Impacts of Food Taxes and Subsidies affecting Ultra Processed Food, NIHR174753, £818.1k, 2026–2028, 1 Feb 2026

• Hampshire and Isle of Wight Healthcare Nhs Foundation Trust

  Research for Patient Benefit, EMPoWER Effectiveness of a Multi-modal intervention to Promote Independence and WEllbeing among oldeR adults of South Asian heritage: a feasibility study, NIHR208182, £316.7k, 2026–2028, 1 Feb 2026

• University of Glasgow

  Public Health Research, Natural Experimental Evaluation of increasing the Minimum Unit Price for alcohol in Scotland to 65p (NEEMUP65), NIHR173364, £1.2m, 2026–2028, 1 Feb 2026

• Imperial College London

  Public Health Research, GOLDFINCH (Fiscal INCentives for Health through UPF reduction), NIHR174875, £800.9k, 2026–2028, 1 Feb 2026

• Punto Health

  Invention for Innovation, Not Available, NIHR510914, £86.1k, 2026–2027, 1 Feb 2026

• Brainplus Uk

  Invention for Innovation, Early Digital CST for Dementia: Detecting Cognitive Decline to Prevent Frailty and Falls, NIHR510823, £97.3k, 2026, 1 Jan 2026

• CrossSense

  Invention for Innovation, CrossSense: feasibility for targeting psychosocial pathways to prevent multimorbidity in dementia, NIHR510703, £100.7k, 2026, 1 Jan 2026

Sources: fundingawards.nihr.ac.uk

• Accelerated Biological Aging and Risk of Early-Onset Colorectal Cancer: Findings from a Large Prospective East Asian Cohort

  5 Oct 2026

• Community-based interventions for managing frailty among people experiencing homelessness: a systematic review

  761, 2 Oct 2026

• Childhood socioeconomic circumstances and adult mortality: a systematic review and meta-analysis

  1 Oct 2026

• Dynamic depression phenotypes and frailty accumulation: A longitudinal study of four Global Aging cohorts

  1 Oct 2026

• Effectiveness of Adding GLP-1 Receptor Agonists to SGLT2 Inhibitor Therapy in Chronic Kidney Disease: A Population Based Study

  27 Sept 2026

• Gene-environment interactions shape cytokine-mediated inflammation and cardiovascular risk

  18 Sept 2026

• Body Roundness Index, MASLD risk and long-term follow-up outcomes among the general population

  18 Sept 2026

• Controlled Drug Use and Falls in Older People With Neurogenic Claudication: Secondary Analysis of the BOOST RCT

  NIHR203301, 17 Sept 2026

• No association between Epstein-Barr Virus serostatus and infection-related mortality in 9,429 British adults: a UK Biobank study

  17 Sept 2026

• Adenosine Deaminase-Mediated Purine Dysfunction Leads to DNA Repair Inhibition and Senescence in Sporadic Amyotrophic Lateral Sclerosis

  NF-SI-0617-10077, 16 Sept 2026

• Prognostic factors in mid-life for predicting subsequent frailty: systematic literature review

  303693, 15 Sept 2026

• Brain-age in ultra-low-field MRI: How well does it work?

  Early Career Investigator Award, 15 Sept 2026

• The impacts of environmental heat on menopausal symptoms: A global scoping review

  NIHR 207406, 15 Sept 2026

• Prognostic Value of AI-derived Ventricular Imaging Phenotypes from Cardiac CTA for Long-term Risk of Myocardial Infarction ---Analysis of SCOT-HEART Trial

  10 Sept 2026

• Enhanced power and transferability for genetics-driven metabolomic biomarker discovery in admixed American cohorts

  NIHR203312, BRC-1215-20014, NIHR BTRU-2014-10024, NIHR203337, 7 Sept 2026

• Hypertrophic cardiomyopathy: a genome-wide association meta-analysis and polygenic risk score

  N/A, 4 Sept 2026

• Longitudinal dynamics of gene expression and metabolomics in an aging population cohort

  3 Sept 2026

• Evaluation of the FI-Lab, a laboratory-based, automated frailty index for acute care: A multicohort study

  Funder of UK Biobank Database, 1 Sept 2026

• Prevalence of target organ damage in rural Kenya and The Gambia: a cross-sectional study

  1 Sept 2026

• Prognostic Value of Cardiac MRI-derived Diastolic Function for Adverse Cardiovascular Outcomes: Insights from UK Biobank

  NIHR203330, 1 Sept 2026

Sources: api.crossref.org, pubmed.ncbi.nlm.nih.gov

• Effectiveness and cost-effectiveness of the Keep-On-Keep-Up digital falls prevention programme in community-dwelling older adults: results of a randomised controlled trial

  Age and ageing, 24 Sept 2026

• Exercise-based cardiac rehabilitation for coronary heart disease

  The Cochrane database of systematic reviews, 17 Sept 2026

• Prevalence of target organ damage in rural Kenya and The Gambia: a cross-sectional study

  The Lancet regional health. Africa, 13 Sept 2026

• A digital intervention to protect cognitive health in older adults with cognitive impairment: a three-arm, open-label, randomised controlled trial

  The Lancet. Primary care, 9 Sept 2026

• An integrated lifestyle intervention for mitigation of adverse effects associated with androgen deprivation therapy for prostate cancer (STAMINA): a multicentre, randomised trial

  The Lancet. Oncology, 4 Sept 2026

• Causal roles of phenotypic age and metabolic health on dementia: a Mendelian randomisation and structure learning study

  medRxiv, 3 Sept 2026

• Scalable behavioural weight management programmes for the prevention and treatment of type 2 diabetes: research programme including three RCTs

  National Institute for Health and Care Research, Southampton (UK), 30 Aug 2026

• Sex differences in trajectories to cardio-renal and mental health outcomes following the onset of type 2 diabetes: An observational cohort study using multi-state analysis in the UK Clinical Practice Research Datalink

  PLoS medicine, 25 Aug 2026

• Insulin resistance and brain health in midlife: a potential dementia prevention target

  EBioMedicine, 21 Aug 2026

• Multiple long-term conditions and their association with quality of life and healthcare utilisation among adults in India: a cross-sectional analysis of WHO SAGE Waves 2 and 3

  BMJ open, 11 Aug 2026

• Development and evaluation of the electronic frailty index+ (eFI+) tool for older people: prognostic prediction modelling with integrated decision curve and health economic analysis

  Health technology assessment (Winchester, England), 10 Aug 2026

• Appraisal of joint tobacco and alcohol tax interventions for harm reduction in the UK: the SYNTAX integrated evidence synthesis project

  Public health research (Southampton, England), 10 Aug 2026

• Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study

  The lancet. Diabetes & endocrinology, 8 Jul 2026

• An ancestry-enriched PIEZO1 missense variant biases HbA1c-based diagnosis of prediabetes and type 2 diabetes in South Asians

  medRxiv, 30 Mar 2026

• Prevalence and outcomes of intrinsic capacity impairments assessed using the WHO Integrated Care for Older People (ICOPE) framework in The Gambia, South Africa, and Zimbabwe: a cross-sectional study

  The Lancet. Global health, 20 Feb 2026

• Cognitive Performance in People at High Risk of Parkinson's Disease

  AAIC 2025 abstract, 25 Dec 2025

• Clinical validation of the Harmonised Cognitive Assessment Protocol (HCAP) in a Northern Irish population

  AAIC 2025 abstract, 23 Dec 2025

• Consensus recommendations for dementia risk reduction policy: Insights from a multidisciplinary modified‐Delphi process

  AAIC 2025 abstract, 23 Dec 2025

• Population health and health sector cost impacts of the UK Soft Drinks Industry Levy: a modelling study

  Public health research (Southampton, England), 6 Dec 2025

• Cognitive decline before and after mid-to-late-life continuing education in England: a matched longitudinal analysis of a prospective cohort study

  The Lancet regional health. Europe, 29 Oct 2025